An expert group from the US drug agency FDA does not agree with the general administration of a third dose of the corona vaccine from Pfizer and BioNTech. After hours of discussion, the scientists concluded on Friday that the available data does not justify widespread adoption of a booster vaccine for people over 16. US President Joe Biden had previously spoken out in favor of a booster vaccine after eight months.
–
Recently, researchers in the journal The Lancet also expressed their doubts about booster vaccinations against COVID-19. “Current data do not show the need for widespread booster vaccines in populations with an effective, complete vaccination course,” it said. The limited number of vaccine doses worldwide could best be used to protect people at high risk or who have not yet been vaccinated.
The FDA expert group spoke out on Friday for the use of booster vaccines for people over 65 and high-risk patients. According to them, healthcare personnel also fall within the latter group.
– .
